Survey of expert practice and perceptions of the supporting clinical evidence for the management of uveitis-related cataract and cystoid macular oedema

Ocular Immunology and Inflammation

Volumn 19, Issue 5, 2011, Pages 353-357

  Sreekantam, Sreekanth ^a   Denniston, Alastair K O ^a   Murray, Philip I ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Cataract; Clinical evidence; Cystoid macular edema; Survey; Uveitis

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOSPORIN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TUMOR NECROSIS FACTOR INHIBITOR;

ARTICLE; CATARACT; CATARACT EXTRACTION; EVIDENCE BASED PRACTICE; HUMAN; MEDICAL DECISION MAKING; MEDICAL EXPERT; QUESTIONNAIRE; RETINA MACULA CYSTOID EDEMA; UVEITIS;

ADRENAL CORTEX HORMONES; ADULT; ANTI-BACTERIAL AGENTS; AZATHIOPRINE; CATARACT; CATARACT EXTRACTION; CYCLOSPORINE; EXPERT TESTIMONY; FEMALE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MACULAR EDEMA; MALE; METHOTREXATE; MIDDLE AGED; MYCOPHENOLIC ACID; OPHTHALMOLOGIC SURGICAL PROCEDURES; QUESTIONNAIRES; UVEITIS; YOUNG ADULT;

EID: 80053621148     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2011.592260     Document Type: Article

References (15)

1. Durrani OM, Meads CA, Murray PI. Uveitis: a potentially blinding disease. Ophthalmologica. 2004;218:223-236. (Pubitemid 38969828)
2. Forrester JV. Intermediate and posterior uveitis. Chem Immunol Allergy. 2007;92:228-243. (Pubitemid 47096912)
3. Rothova A, Sultorp-van Schulten MSA, Treffers WF, et al. Causes and frequency of blindness in patients with intraocular infammatory disease. Br J Ophthalmol. 1996;80:332-336. (Pubitemid 26113585)
4. Durrani OM, Tehrani NN, Marr JE, et al. Degree, duration, and causes of visual loss in uveitis. Br J Ophthalmol. 2004;88:1159-1162. (Pubitemid 39141376)
5. Carr DR, Jacox AK, Chapman CR, et al. Acute pain management: operative or medical procedures and trauma, No. 1. Rockville, MD: AHCPR Pub. No. 92-0032; Public Health Service; U.S. Dept. of Health and Human Services, 1992.
6. Hadorn DC, Baker D, Hodges JS, et al. Rating the quality of evidence for clinical practice guidelines. J Clin Epidemiol. 1996;49:749-754. (Pubitemid 26280725)
7. Elwood JM. The diagnosis of causation. In Elwood JM, Critical Appraisal of Epidemiological Studies and Clinical Trials, 3rd ed. New York: Oxford University Press; 2007: 326-330.
8. Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ. 2001;323: 334-336. (Pubitemid 32744465)
9. Meacock WR, Spalton DJ, Bender l, et al. Steroid prophylaxis in eyes with uveitis undergoing phacoemulsifcation. Br J Ophthalmol. 2004;88:1122-1124. (Pubitemid 39141369)
10. Alió Jl, Chipont E, BenEzra D, et al. Comparative performance of intraocular lenses in eyes with cataract and uveitis. J Cataract Refract Surg. 2002;28:2096-2108. (Pubitemid 36026086)
11. Roesel M, Heinz C, Heimes B, et al. Uveal and capsular biocompatibility of two foldable acrylic intraocular lenses in patients with endogenous uveitis-a prospective randomized study. Graefes Arch Clin Exp Ophthalmol. 2008;246:1609-1615.
12. Forester JV, Okada AA, BenEzra D, Ohno S. Medical management of posterior segment intraocular infammation. In Forester JV, Okada AA, BenEzra D, Ohno S, eds. Posterior Segment Intraocular Infammation Guidelines. The Hague: Kluger; 151-161.
13. Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular infammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130:492-513.
14. Murray PI. Idiopathic (autoimmune) sight-threatening uveitis. In: Wormald R, Smeeth l, Henshaw K, eds, Evidence-based Ophthalmology. london: BMJ Books; 2004: 167-173.
15. Okada AA. Noninfectious uveitis: a scarcity of randomized clinical trials. Arch Ophthalmol. 2005;123:682-683. (Pubitemid 40695517)